Product Information

DORZOLAMIDE-TIMOLOL EYE DROPS is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.9161 per ML under NDC 62332055310. Its NADAC has been published 78 times since May 21, 2025.

FDA first approved this application on May 4, 2021. Its Orange Book therapeutic-equivalence code is AT1.

Strength

20; 5 mg/mL; mg/mL

NDC

62332055310

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213099

FDA Approved

5/4/2021

TE Code

AT1

On Market Since

5/4/2021

Pharmacological Classes

Adrenergic beta-Antagonists
Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors
beta-Adrenergic Blocker

Price Statistics

The NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has been published 78 times since May 21, 2025, and over the history we have for it it has declined 20.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9161 per ML
All-time high$1.1578 (Jun 11, 2025)
All-time low$0.8853 (Jul 22, 2026)
52-week high$0.9641
52-week low$0.8853
Median price$0.9421
Average price$0.9742
Largest weekly change-4.3% (Sep 17, 2025)
Weeks tracked78
Tracking sinceMay 21, 2025

Price History

1W

0.0%

1M

+2.6%

3M

+2.8%

6M

-1.5%

1Y

-8.5%

3Y

N/A

5Y

N/A

All

-20.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DORZOLAMIDE-TIMOLOL EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL EYE DROPS, manufactured by Alembic Pharmaceuticals Inc., is $0.9161 per ML (NDC 62332055310), effective Nov 11, 2026.

How has the price of DORZOLAMIDE-TIMOLOL EYE DROPS changed over time?

Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has declined 20.9%. It has been tracked across 78 weekly CMS publications since May 21, 2025.

What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL EYE DROPS?

Since May 21, 2025, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has ranged from a low of $0.8853 (Jul 22, 2026) to a high of $1.1578 (Jun 11, 2025), with a median of $0.9421 per ML.

Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL EYE DROPS?

No other NADAC-published product currently shares the active ingredient and strength of DORZOLAMIDE-TIMOLOL EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DORZOLAMIDE-TIMOLOL EYE DROPS?

DORZOLAMIDE-TIMOLOL EYE DROPS (NDC 62332055310) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.